Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Combined PPARg Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors.

Leung DTH, Nguyen T, Oliver EM, Matti J, Alexiadis M, Silke J, Jobling TW, Fuller PJ, Chu S.

Mol Cancer Ther. 2018 Dec 7. pii: molcanther.0078.2018. doi: 10.1158/1535-7163.MCT-18-0078. [Epub ahead of print]

PMID:
30530769
2.

Trabecular bone score in adults with cerebral palsy.

Trinh A, Wong P, Fahey MC, Ebeling PR, Fuller PJ, Milat F.

Bone. 2018 Dec;117:1-5. doi: 10.1016/j.bone.2018.09.001. Epub 2018 Sep 5.

PMID:
30193871
3.

Mutational Landscape of Ovarian Adult Granulosa Cell Tumors from Whole Exome and Targeted TERT Promoter Sequencing.

Alexiadis M, Rowley SM, Chu S, Leung DTH, Stewart CJR, Amarasinghe KC, Campbell IG, Fuller PJ.

Mol Cancer Res. 2018 Aug 30. doi: 10.1158/1541-7786.MCR-18-0359. [Epub ahead of print]

PMID:
30166312
4.

Is it time to screen all patients with hypertension for primary aldosteronism?

Yang J, Fuller PJ, Stowasser M.

Med J Aust. 2018 Jul 16;209(2):57-59. No abstract available.

PMID:
29996750
5.

Saline suppression test parameters may predict bilateral subtypes of primary aldosteronism.

Hashimura H, Shen J, Fuller PJ, Chee NYN, Doery JCG, Chong W, Choy KW, Gwini S, Yang J.

Clin Endocrinol (Oxf). 2018 Sep;89(3):308-313. doi: 10.1111/cen.13757. Epub 2018 Jun 26.

PMID:
29873811
6.

Recurrent vertebral fractures in a young adult: a closer look at bone health in type 1 diabetes mellitus.

Thong EP, Catford S, Fletcher J, Wong P, Fuller PJ, Teede H, Milat F.

Endocrinol Diabetes Metab Case Rep. 2018 May 10;2018. pii: 18-0010. doi: 10.1530/EDM-18-0010. eCollection 2018.

7.

Fat-Bone Interactions in Adults With Spina Bifida.

Trinh A, Wong P, Sakthivel A, Fahey MC, Hennel S, Brown J, Strauss BJ, Ebeling PR, Fuller PJ, Milat F.

J Endocr Soc. 2017 Sep 27;1(10):1301-1311. doi: 10.1210/js.2017-00258. eCollection 2017 Oct 1.

8.

Minimal-trauma ankle fractures predominate during pregnancy: a 17-year retrospective study.

Herath M, Wong P, Trinh A, Allan CA, Wallace EM, Ebeling PR, Fuller PJ, Milat F.

Arch Osteoporos. 2017 Sep 30;12(1):86. doi: 10.1007/s11657-017-0380-x.

PMID:
28965301
9.

Deoxycorticosterone/Salt-Mediated Cardiac Inflammation and Fibrosis Are Dependent on Functional CLOCK Signaling in Male Mice.

Fletcher EK, Morgan J, Kennaway DR, Bienvenu LA, Rickard AJ, Delbridge LMD, Fuller PJ, Clyne CD, Young MJ.

Endocrinology. 2017 Sep 1;158(9):2906-2917. doi: 10.1210/en.2016-1911.

PMID:
28911177
10.

Urolithiasis is prevalent and associated with reduced bone mineral density in β-thalassaemia major.

Wong P, Milat F, Fuller PJ, Kerr PG, Doery JCG, Oh DH, Jackson D, Gillespie MT, Bowden DK, Pasricha SR, Lau KK.

Intern Med J. 2017 Sep;47(9):1064-1067. doi: 10.1111/imj.13533.

PMID:
28891172
11.

30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Coregulators as mediators of mineralocorticoid receptor signalling diversity.

Fuller PJ, Yang J, Young MJ.

J Endocrinol. 2017 Jul;234(1):T23-T34. doi: 10.1530/JOE-17-0060. Review.

PMID:
28634265
12.

Farnesoid X Receptor Agonist Treatment Alters Bile Acid Metabolism but Exacerbates Liver Damage in a Piglet Model of Short-Bowel Syndrome.

Pereira-Fantini PM, Lapthorne S, Gahan CGM, Joyce SA, Charles J, Fuller PJ, Bines JE.

Cell Mol Gastroenterol Hepatol. 2017 Mar 6;4(1):65-74. doi: 10.1016/j.jcmgh.2017.02.008. eCollection 2017 Jul.

13.

Diagnosing endocrine hypertension: a practical approach.

Yang J, Shen J, Fuller PJ.

Nephrology (Carlton). 2017 Sep;22(9):663-677. doi: 10.1111/nep.13078. Review.

PMID:
28556585
14.

Optimizing bone health in cerebral palsy across the lifespan.

Trinh A, Fahey MC, Brown J, Fuller PJ, Milat F.

Dev Med Child Neurol. 2017 Feb;59(2):232-233. doi: 10.1111/dmcn.13355. No abstract available.

15.

Review: The role of multiple placental glucocorticoid receptor isoforms in adapting to the maternal environment and regulating fetal growth.

Clifton VL, Cuffe J, Moritz KM, Cole TJ, Fuller PJ, Lu NZ, Kumar S, Chong S, Saif Z.

Placenta. 2017 Jun;54:24-29. doi: 10.1016/j.placenta.2016.12.017. Epub 2016 Dec 19. Review.

PMID:
28017357
16.

Steroid sulfatase is increased in the placentas and whole blood of women with early-onset preeclampsia.

Gratton AM, Ye L, Brownfoot FC, Hannan NJ, Whitehead C, Cannon P, Deo M, Fuller PJ, Tong S, Kaitu'u-Lino TJ.

Placenta. 2016 Dec;48:72-79. doi: 10.1016/j.placenta.2016.10.008. Epub 2016 Oct 15.

PMID:
27871476
17.

Genetics and genomics of ovarian sex cord-stromal tumors.

Fuller PJ, Leung D, Chu S.

Clin Genet. 2017 Feb;91(2):285-291. doi: 10.1111/cge.12917. Review.

PMID:
27813081
18.

Proanthocyanidins block aldosterone-dependent up-regulation of cardiac gamma ENaC and Nedd4-2 inactivation via SGK1.

Galiana-Simal A, Olivares-Álvaro E, Klett-Mingo M, Ruiz-Roso MB, Ballesteros S, de Las Heras N, Fuller PJ, Lahera V, Martín-Fernández B.

J Nutr Biochem. 2016 Nov;37:13-19. doi: 10.1016/j.jnutbio.2016.07.012. Epub 2016 Aug 14.

PMID:
27592201
19.

Fractures in spina bifida from childhood to young adulthood.

Trinh A, Wong P, Brown J, Hennel S, Ebeling PR, Fuller PJ, Milat F.

Osteoporos Int. 2017 Jan;28(1):399-406. doi: 10.1007/s00198-016-3742-0. Epub 2016 Aug 24.

PMID:
27553445
20.

Adrenal Cushing's syndrome in pregnancy: Clinical and molecular characterisation of a case.

Trinh A, Chan I, Alexiadis M, Pell M, Kumar B, Fuller PJ.

Obstet Med. 2016 Mar;9(1):43-5. doi: 10.1177/1753495X15618542. Epub 2015 Dec 9.

21.

Endocrine Affairs of the Heart.

Fuller PJ, Young MJ.

Endocrinology. 2016 Jul;157(7):2578-82. doi: 10.1210/en.2016-1375. No abstract available.

PMID:
27363869
22.

Bone Disease in Thalassemia: A Molecular and Clinical Overview.

Wong P, Fuller PJ, Gillespie MT, Milat F.

Endocr Rev. 2016 Aug;37(4):320-46. doi: 10.1210/er.2015-1105. Epub 2016 Jun 16. Review.

PMID:
27309522
23.

Cardiac Tissue Injury and Remodeling Is Dependent Upon MR Regulation of Activation Pathways in Cardiac Tissue Macrophages.

Shen JZ, Morgan J, Tesch GH, Rickard AJ, Chrissobolis S, Drummond GR, Fuller PJ, Young MJ.

Endocrinology. 2016 Aug;157(8):3213-23. doi: 10.1210/en.2016-1040. Epub 2016 Jun 2.

PMID:
27253999
24.

Severe acute phase response after intravenous zoledronic acid in adult patients with cerebral palsy.

Trinh A, Wong P, Ebeling PR, Fuller PJ, Milat F.

Intern Med J. 2016 Apr;46(4):506-7. doi: 10.1111/imj.13030. No abstract available.

PMID:
27062209
25.

Transcriptomic analysis of stage 1 versus advanced adult granulosa cell tumors.

Alexiadis M, Chu S, Leung D, Gould JA, Jobling T, Fuller PJ.

Oncotarget. 2016 Mar 22;7(12):14207-19. doi: 10.18632/oncotarget.7422.

26.

Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.

Whitehead CL, McNamara H, Walker SP, Alexiadis M, Fuller PJ, Vickers DK, Hannan NJ, Hastie R, Tuohey L, Kaitu'u-Lino TJ, Tong S.

Am J Obstet Gynecol. 2016 Apr;214(4):521.e1-521.e8. doi: 10.1016/j.ajog.2016.01.191. Epub 2016 Feb 12.

PMID:
26880734
27.

Deferasirox at therapeutic doses is associated with dose-dependent hypercalciuria.

Wong P, Polkinghorne K, Kerr PG, Doery JC, Gillespie MT, Larmour I, Fuller PJ, Bowden DK, Milat F.

Bone. 2016 Apr;85:55-8. doi: 10.1016/j.bone.2016.01.011. Epub 2016 Jan 21.

PMID:
26802257
28.

Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.

Leung DTH, Fuller PJ, Chu S.

Int J Biochem Cell Biol. 2016 Mar;72:51-54. doi: 10.1016/j.biocel.2016.01.003. Epub 2016 Jan 11. Review.

PMID:
26791928
29.

Musculoskeletal and Endocrine Health in Adults With Cerebral Palsy: New Opportunities for Intervention.

Trinh A, Wong P, Fahey MC, Brown J, Churchyard A, Strauss BJ, Ebeling PR, Fuller PJ, Milat F.

J Clin Endocrinol Metab. 2016 Mar;101(3):1190-7. doi: 10.1210/jc.2015-3888. Epub 2016 Jan 11.

PMID:
26751195
30.

Role of adrenal vein sampling in primary aldosteronism: the Monash Health experience.

Teng J, Hutchinson ME, Doery JC, Choy KW, Chong W, Fuller PJ, Yang J.

Intern Med J. 2015 Nov;45(11):1141-6. doi: 10.1111/imj.12873.

PMID:
26256544
31.

Management of hypoparathyroidism in pregnancy and lactation - A report of 10 cases.

Hatswell BL, Allan CA, Teng J, Wong P, Ebeling PR, Wallace EM, Fuller PJ, Milat F.

Bone Rep. 2015 Jun 30;3:15-19. doi: 10.1016/j.bonr.2015.05.005. eCollection 2015 Dec.

32.

Tyrosine Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of Granulosa Cell Tumors of the Ovary.

Jamieson S, Fuller PJ.

Int J Gynecol Cancer. 2015 Sep;25(7):1224-31. doi: 10.1097/IGC.0000000000000479.

PMID:
26067856
33.

Aldosterone-Mediated Renal Sodium Transport Requires Intact Mineralocorticoid Receptor DNA-Binding in the Mouse.

Cole TJ, Terella L, Morgan J, Alexiadis M, Yao YZ, Enriori P, Young MJ, Fuller PJ.

Endocrinology. 2015 Aug;156(8):2958-68. doi: 10.1210/en.2015-1008. Epub 2015 Jun 11.

PMID:
26066075
34.

Expression of eight glucocorticoid receptor isoforms in the human preterm placenta vary with fetal sex and birthweight.

Saif Z, Hodyl NA, Stark MJ, Fuller PJ, Cole T, Lu N, Clifton VL.

Placenta. 2015 Jul;36(7):723-30. doi: 10.1016/j.placenta.2015.05.001. Epub 2015 May 9.

35.

Somatic Mutations of FOXE1 in Papillary Thyroid Cancer.

Mond M, Bullock M, Yao Y, Clifton-Bligh RJ, Gilfillan C, Fuller PJ.

Thyroid. 2015 Aug;25(8):904-10. doi: 10.1089/thy.2015.0030. Epub 2015 Jun 19.

PMID:
25950909
36.

Novel interactions of the mineralocorticoid receptor.

Fuller PJ.

Mol Cell Endocrinol. 2015 Jun 15;408:33-7. doi: 10.1016/j.mce.2015.01.027. Epub 2015 Feb 7. Review.

PMID:
25662276
37.

GEMIN4 functions as a coregulator of the mineralocorticoid receptor.

Yang J, Fuller PJ, Morgan J, Shibata H, Clyne CD, Young MJ.

J Mol Endocrinol. 2015 Apr;54(2):149-60. doi: 10.1530/JME-14-0078. Epub 2015 Jan 2.

PMID:
25555524
38.

Beneficial effects of proanthocyanidins in the cardiac alterations induced by aldosterone in rat heart through mineralocorticoid receptor blockade.

Martín-Fernández B, de las Heras N, Valero-Muñoz M, Ballesteros S, Yao YZ, Stanton PG, Fuller PJ, Lahera V.

PLoS One. 2014 Oct 29;9(10):e111104. doi: 10.1371/journal.pone.0111104. eCollection 2014.

39.

Duelling receptors: estrogen receptor versus mineralocorticoid receptor in the cardiovascular system.

Fuller PJ, Young MJ.

Endocrinology. 2014 Nov;155(11):4117-9. doi: 10.1210/en.2014-1778. No abstract available.

PMID:
25325425
40.

Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease.

Hilton HN, Doan TB, Graham JD, Oakes SR, Silvestri A, Santucci N, Kantimm S, Huschtscha LI, Ormandy CJ, Funder JW, Simpson ER, Kuczek ES, Leedman PJ, Tilley WD, Fuller PJ, Muscat GE, Clarke CL.

Oncotarget. 2014 Sep 30;5(18):8651-64.

41.

Use of phage display to identify novel mineralocorticoid receptor-interacting proteins.

Yang J, Fuller PJ, Morgan J, Shibata H, McDonnell DP, Clyne CD, Young MJ.

Mol Endocrinol. 2014 Sep;28(9):1571-84. doi: 10.1210/me.2014-1101. Epub 2014 Jul 7.

42.

Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease.

Pereira-Fantini PM, Lapthorne S, Joyce SA, Dellios NL, Wilson G, Fouhy F, Thomas SL, Scurr M, Hill C, Gahan CG, Cotter PD, Fuller PJ, Hardikar W, Bines JE.

J Hepatol. 2014 Nov;61(5):1115-25. doi: 10.1016/j.jhep.2014.06.025. Epub 2014 Jul 3.

PMID:
24999016
43.

PRMT2 and RORγ expression are associated with breast cancer survival outcomes.

Oh TG, Bailey P, Dray E, Smith AG, Goode J, Eriksson N, Funder JW, Fuller PJ, Simpson ER, Tilley WD, Leedman PJ, Clarke CL, Grimmond S, Dowhan DH, Muscat GE.

Mol Endocrinol. 2014 Jul;28(7):1166-85. doi: 10.1210/me.2013-1403. Epub 2014 Jun 9.

44.

Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator.

Rogerson FM, Yao YZ, Young MJ, Fuller PJ.

FASEB J. 2014 Oct;28(10):4200-10. doi: 10.1096/fj.13-242479. Epub 2014 Jun 6.

PMID:
24907116
45.

Mutation profile of differentiated thyroid tumours in an Australian urban population.

Mond M, Alexiadis M, Fuller PJ, Gilfillan C.

Intern Med J. 2014 Aug;44(8):727-34. doi: 10.1111/imj.12476.

PMID:
24862939
46.

Breast cancer prognosis predicted by nuclear receptor-coregulator networks.

Doan TB, Eriksson NA, Graham D, Funder JW, Simpson ER, Kuczek ES, Clyne C, Leedman PJ, Tilley WD, Fuller PJ, Muscat GE, Clarke CL.

Mol Oncol. 2014 Jul;8(5):998-1013. doi: 10.1016/j.molonc.2014.03.017. Epub 2014 Apr 4.

47.

Thalassemia bone disease: a 19-year longitudinal analysis.

Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Kerr PG, Doery JC, Paul E, Bowden DK, Strauss BJ, Milat F.

J Bone Miner Res. 2014 Nov;29(11):2468-73. doi: 10.1002/jbmr.2266.

48.

Nuclear receptor expression in human differentiated thyroid tumors.

Mond M, Alexiadis M, Eriksson N, Davis MJ, Muscat GE, Fuller PJ, Gilfillan C.

Thyroid. 2014 Jun;24(6):1000-11. doi: 10.1089/thy.2013.0509. Epub 2014 May 19.

PMID:
24559275
49.

CCL2-dependent macrophage recruitment is critical for mineralocorticoid receptor-mediated cardiac fibrosis, inflammation, and blood pressure responses in male mice.

Shen JZ, Morgan J, Tesch GH, Fuller PJ, Young MJ.

Endocrinology. 2014 Mar;155(3):1057-66. doi: 10.1210/en.2013-1772. Epub 2014 Jan 15.

PMID:
24428529
50.

Supplemental Content

Loading ...
Support Center